vs
Steris（STE）与Ubiquiti Inc.（UI）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是Ubiquiti Inc.的1.8倍（$1.5B vs $814.9M），Ubiquiti Inc.净利率更高（28.7% vs 12.9%，领先15.8%），Ubiquiti Inc.同比增速更快（35.8% vs 9.2%），Ubiquiti Inc.自由现金流更多（$260.3M vs $199.5M），过去两年Ubiquiti Inc.的营收复合增速更高（28.6% vs 15.8%）
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
Ubiquiti Inc.是一家美国科技企业，2003年于加利福尼亚州圣何塞成立，目前总部位于纽约。公司旗下拥有多个品牌，主营面向企业及家庭用户的有线、无线数据通信产品的研发、生产与销售。
STE vs UI — 直观对比
营收规模更大
STE
是对方的1.8倍
$814.9M
营收增速更快
UI
高出26.7%
9.2%
净利率更高
UI
高出15.8%
12.9%
自由现金流更多
UI
多$60.8M
$199.5M
两年增速更快
UI
近两年复合增速
15.8%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $814.9M |
| 净利润 | $192.9M | $233.6M |
| 毛利率 | 43.8% | 45.9% |
| 营业利润率 | 18.3% | 35.9% |
| 净利率 | 12.9% | 28.7% |
| 营收同比 | 9.2% | 35.8% |
| 净利润同比 | 11.2% | 70.8% |
| 每股收益（稀释后） | $1.96 | $3.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STEUI
| Q4 25 | $1.5B | $814.9M | ||
| Q3 25 | $1.5B | $733.8M | ||
| Q2 25 | $1.4B | $759.2M | ||
| Q1 25 | $1.5B | $664.2M | ||
| Q4 24 | $1.4B | $599.9M | ||
| Q3 24 | $1.3B | $550.3M | ||
| Q2 24 | $1.3B | $507.5M | ||
| Q1 24 | $1.1B | $493.0M |
净利润STEUI
| Q4 25 | $192.9M | $233.6M | ||
| Q3 25 | $191.9M | $207.9M | ||
| Q2 25 | $177.4M | $266.7M | ||
| Q1 25 | $145.7M | $180.4M | ||
| Q4 24 | $173.5M | $136.8M | ||
| Q3 24 | $150.0M | $128.0M | ||
| Q2 24 | $145.4M | $103.8M | ||
| Q1 24 | $-1.4M | $76.3M |
毛利率STEUI
| Q4 25 | 43.8% | 45.9% | ||
| Q3 25 | 44.2% | 46.0% | ||
| Q2 25 | 45.1% | 45.1% | ||
| Q1 25 | 43.3% | 44.5% | ||
| Q4 24 | 44.5% | 41.2% | ||
| Q3 24 | 43.6% | 42.1% | ||
| Q2 24 | 44.7% | 40.2% | ||
| Q1 24 | 40.2% | 35.3% |
营业利润率STEUI
| Q4 25 | 18.3% | 35.9% | ||
| Q3 25 | 18.2% | 35.7% | ||
| Q2 25 | 17.7% | 34.4% | ||
| Q1 25 | 14.6% | 34.2% | ||
| Q4 24 | 17.9% | 29.8% | ||
| Q3 24 | 16.5% | 30.7% | ||
| Q2 24 | 14.5% | 27.3% | ||
| Q1 24 | 22.0% | 22.6% |
净利率STEUI
| Q4 25 | 12.9% | 28.7% | ||
| Q3 25 | 13.1% | 28.3% | ||
| Q2 25 | 12.8% | 35.1% | ||
| Q1 25 | 9.8% | 27.2% | ||
| Q4 24 | 12.7% | 22.8% | ||
| Q3 24 | 11.3% | 23.3% | ||
| Q2 24 | 11.4% | 20.5% | ||
| Q1 24 | -0.1% | 15.5% |
每股收益（稀释后）STEUI
| Q4 25 | $1.96 | $3.86 | ||
| Q3 25 | $1.94 | $3.43 | ||
| Q2 25 | $1.79 | $4.40 | ||
| Q1 25 | $1.48 | $2.98 | ||
| Q4 24 | $1.75 | $2.26 | ||
| Q3 24 | $1.51 | $2.12 | ||
| Q2 24 | $1.46 | $1.72 | ||
| Q1 24 | $-0.02 | $1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $302.8M |
| 总债务越低越好 | $1.9B | $47.5M |
| 股东权益账面价值 | $7.2B | $1.0B |
| 总资产 | $10.6B | $1.6B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资STEUI
| Q4 25 | $423.7M | $302.8M | ||
| Q3 25 | $319.2M | $177.2M | ||
| Q2 25 | $279.7M | $149.7M | ||
| Q1 25 | $171.7M | $151.0M | ||
| Q4 24 | $155.2M | $133.1M | ||
| Q3 24 | $172.2M | $165.2M | ||
| Q2 24 | $198.3M | $126.3M | ||
| Q1 24 | $207.0M | $102.5M |
总债务STEUI
| Q4 25 | $1.9B | $47.5M | ||
| Q3 25 | $1.9B | $133.8M | ||
| Q2 25 | $1.9B | $250.0M | ||
| Q1 25 | $1.9B | $340.0M | ||
| Q4 24 | $2.0B | $406.3M | ||
| Q3 24 | $2.2B | $552.5M | ||
| Q2 24 | $2.2B | $708.1M | ||
| Q1 24 | $3.1B | $877.5M |
股东权益STEUI
| Q4 25 | $7.2B | $1.0B | ||
| Q3 25 | $7.0B | $828.4M | ||
| Q2 25 | $7.0B | $668.3M | ||
| Q1 25 | $6.6B | $436.1M | ||
| Q4 24 | $6.4B | $290.4M | ||
| Q3 24 | $6.6B | $188.1M | ||
| Q2 24 | $6.4B | $95.1M | ||
| Q1 24 | $6.3B | $25.9M |
总资产STEUI
| Q4 25 | $10.6B | $1.6B | ||
| Q3 25 | $10.4B | $1.5B | ||
| Q2 25 | $10.4B | $1.5B | ||
| Q1 25 | $10.1B | $1.3B | ||
| Q4 24 | $10.0B | $1.2B | ||
| Q3 24 | $10.2B | $1.2B | ||
| Q2 24 | $10.1B | $1.2B | ||
| Q1 24 | $11.1B | $1.2B |
负债/权益比STEUI
| Q4 25 | 0.27× | 0.05× | ||
| Q3 25 | 0.27× | 0.16× | ||
| Q2 25 | 0.27× | 0.37× | ||
| Q1 25 | 0.29× | 0.78× | ||
| Q4 24 | 0.32× | 1.40× | ||
| Q3 24 | 0.33× | 2.94× | ||
| Q2 24 | 0.35× | 7.45× | ||
| Q1 24 | 0.50× | 33.92× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $298.2M | $263.9M |
| 自由现金流经营现金流 - 资本支出 | $199.5M | $260.3M |
| 自由现金流率自由现金流/营收 | 13.3% | 31.9% |
| 资本支出强度资本支出/营收 | 6.6% | 0.4% |
| 现金转化率经营现金流/净利润 | 1.55× | 1.13× |
| 过去12个月自由现金流最近4个季度 | $917.1M | $699.5M |
8季度趋势，按日历期对齐
经营现金流STEUI
| Q4 25 | $298.2M | $263.9M | ||
| Q3 25 | $287.8M | $198.5M | ||
| Q2 25 | $420.0M | $130.4M | ||
| Q1 25 | $260.8M | $123.6M | ||
| Q4 24 | $332.8M | $152.4M | ||
| Q3 24 | $250.7M | $233.7M | ||
| Q2 24 | $303.7M | $231.4M | ||
| Q1 24 | $254.8M | $163.9M |
自由现金流STEUI
| Q4 25 | $199.5M | $260.3M | ||
| Q3 25 | $201.3M | $193.3M | ||
| Q2 25 | $326.4M | $125.2M | ||
| Q1 25 | $189.9M | $120.7M | ||
| Q4 24 | $243.6M | $150.4M | ||
| Q3 24 | $148.8M | $231.1M | ||
| Q2 24 | $195.7M | $229.5M | ||
| Q1 24 | $163.3M | $160.6M |
自由现金流率STEUI
| Q4 25 | 13.3% | 31.9% | ||
| Q3 25 | 13.8% | 26.3% | ||
| Q2 25 | 23.5% | 16.5% | ||
| Q1 25 | 12.8% | 18.2% | ||
| Q4 24 | 17.8% | 25.1% | ||
| Q3 24 | 11.2% | 42.0% | ||
| Q2 24 | 15.3% | 45.2% | ||
| Q1 24 | 14.6% | 32.6% |
资本支出强度STEUI
| Q4 25 | 6.6% | 0.4% | ||
| Q3 25 | 5.9% | 0.7% | ||
| Q2 25 | 6.7% | 0.7% | ||
| Q1 25 | 4.8% | 0.4% | ||
| Q4 24 | 6.5% | 0.3% | ||
| Q3 24 | 7.7% | 0.5% | ||
| Q2 24 | 8.4% | 0.4% | ||
| Q1 24 | 8.2% | 0.7% |
现金转化率STEUI
| Q4 25 | 1.55× | 1.13× | ||
| Q3 25 | 1.50× | 0.95× | ||
| Q2 25 | 2.37× | 0.49× | ||
| Q1 25 | 1.79× | 0.68× | ||
| Q4 24 | 1.92× | 1.11× | ||
| Q3 24 | 1.67× | 1.83× | ||
| Q2 24 | 2.09× | 2.23× | ||
| Q1 24 | — | 2.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
